Australia Human Primary Cell Culture Market Size & Outlook
Related Markets
Australia human primary cell culture market highlights
- The Australia human primary cell culture market generated a revenue of USD 62.4 million in 2024 and is expected to reach USD 116.7 million by 2030.
- The Australia market is expected to grow at a CAGR of 11% from 2025 to 2030.
- In terms of segment, primary cells was the largest revenue generating product in 2024.
- Primary Cell Culture Media is the most lucrative product segment registering the fastest growth during the forecast period.
Human primary cell culture market data book summary
| Market revenue in 2024 | USD 62.4 million |
| Market revenue in 2030 | USD 116.7 million |
| Growth rate | 11% (CAGR from 2025 to 2030) |
| Largest segment | Primary cells |
| Fastest growing segment | Primary Cell Culture Media |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Primary Cells, Reagents and Supplements, Primary Cell Culture Media |
Other key industry trends
- In terms of revenue, Australia accounted for 1.6% of the global human primary cell culture market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China human primary cell culture market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 439.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Human Primary Cell Culture Market Scope
Human Primary Cell Culture Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| AllCells | View profile | 51-100 | Alameda, California, United States, North America | https://www.allcells.com |
| Cell Biologics, Inc. | View profile | 1-10 | Chicago, Illinois, United States, North America | http://www.cellbiologics.net |
| Axol Bioscience | View profile | 11-50 | Cambridge, Massachusetts, United States, North America | https://www.axolbio.com |
| ZenBio | View profile | 11-50 | Durham, North Carolina, United States, North America | http://www.zen-bio.com/ |
| PromoCell GmbH | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | http://www.promocell.com/ |
| Stemcell Holdings Inc Ordinary Shares | View profile | - | 1185 Avenue of the Americas, 3rd Floor, New York, NY, United States, 10036 | https://www.stemcell-holdings.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Australia human primary cell culture market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human primary cell culture market will help companies and investors design strategic landscapes.
Primary cells was the largest segment with a revenue share of 39.42% in 2024. Horizon Databook has segmented the Australia human primary cell culture market based on primary cells, reagents and supplements, primary cell culture media covering the revenue growth of each sub-segment from 2018 to 2030.
Australia has established itself as a powerhouse of pharmaceutical and biotechnology innovation, owing to its advanced research facilities, highly qualified researchers, and a regulatory framework that is both firm and flexible.
According to the Australian Trade and Investment Commission, the country is home to over 470 biotechnology companies, creating a vibrant ecosystem for growth.
Australian biotech companies are also contributing to the market's growth by utilizing primary cell culture technologies in their R&D efforts.
Reasons to subscribe to Australia human primary cell culture market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia human primary cell culture market databook
-
Our clientele includes a mix of human primary cell culture market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia human primary cell culture market , including forecasts for subscribers. This country databook contains high-level insights into Australia human primary cell culture market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia Product - Human Primary Cell Culture Market size, 2024 - 2030 (US$M)
Australia Human Primary Cell Culture Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
